Renowned Investment Bank Reiterates Buy Rating For Israeli Medical Company

HC Wainwright & Co. Reiterates Buy on BioLine Rx, Maintains $21 Price Target: A Deep Dive into the Potential of $BLRX.

Disclaimer: The information provided in this article is for informational purposes only and should not be considered financial advice. Always do your own research and consult with a professional before making any investment decisions.

BioLine Rx (NASDAQ: $BLRX), an Israeli biopharmaceutical development company, recently received a reiterated buy rating f…